RTI Surgical Inc (NASDAQ:RTIX) has earned a consensus broker rating score of 3.00 (Hold) from the three brokers that cover the company, Zacks Investment Research reports. Three equities research analysts have rated the stock with a hold recommendation.

Analysts have set a 1-year consensus price target of $5.00 for the company and are predicting that the company will post $0.04 earnings per share for the current quarter, according to Zacks. Zacks has also assigned RTI Surgical an industry rank of 167 out of 265 based on the ratings given to related companies.

A number of equities research analysts have issued reports on the company. Zacks Investment Research upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research note on Friday, October 13th. BidaskClub lowered RTI Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th.

Shares of RTI Surgical (NASDAQ:RTIX) traded up $0.10 during mid-day trading on Thursday, reaching $4.30. The company’s stock had a trading volume of 80,282 shares, compared to its average volume of 117,000. RTI Surgical has a 1-year low of $3.01 and a 1-year high of $6.00. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21. The stock has a market cap of $255.89, a price-to-earnings ratio of -61.43, a PEG ratio of 1.82 and a beta of 1.76.

RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.01. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The business had revenue of $66.69 million during the quarter, compared to analyst estimates of $65.63 million. The company’s revenue was up .2% compared to the same quarter last year. equities analysts anticipate that RTI Surgical will post 0.05 earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of the business. Prudential Financial Inc. purchased a new position in shares of RTI Surgical during the third quarter valued at about $111,000. Citadel Advisors LLC grew its position in shares of RTI Surgical by 85.7% during the third quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock valued at $122,000 after purchasing an additional 12,361 shares in the last quarter. Citigroup Inc. grew its position in shares of RTI Surgical by 2,850.1% during the second quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after purchasing an additional 20,435 shares in the last quarter. Campbell & CO Investment Adviser LLC purchased a new position in shares of RTI Surgical during the third quarter valued at about $144,000. Finally, Thompson Davis & CO. Inc. grew its position in shares of RTI Surgical by 138.8% during the second quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock valued at $147,000 after purchasing an additional 14,577 shares in the last quarter. Institutional investors and hedge funds own 69.90% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “RTI Surgical Inc (RTIX) Given Consensus Rating of “Hold” by Analysts” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/04/rti-surgical-inc-rtix-given-consensus-rating-of-hold-by-analysts.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.